Compare RCEL & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCEL | AMWL |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.5M | 111.4M |
| IPO Year | N/A | 2020 |
| Metric | RCEL | AMWL |
|---|---|---|
| Price | $3.29 | $4.74 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $8.67 | $7.58 |
| AVG Volume (30 Days) | ★ 221.8K | 136.2K |
| Earning Date | 02-12-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $72,401,000.00 | ★ $265,023,000.00 |
| Revenue This Year | $13.12 | N/A |
| Revenue Next Year | $27.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.59 | 4.33 |
| 52 Week Low | $3.22 | $3.71 |
| 52 Week High | $11.25 | $12.95 |
| Indicator | RCEL | AMWL |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 49.10 |
| Support Level | $3.22 | $4.92 |
| Resistance Level | $3.57 | $5.29 |
| Average True Range (ATR) | 0.18 | 0.29 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 14.29 | 24.55 |
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.